Her primary research areas include electronic health records (EHRs), natural language processing (NLP), text mining, clinical data integration analysis, and knowledge discovery from big data. Dr. Wang developed the first framework of quantitative pharmacovigilance using NLP, informatics and statistics on EHRs to detect novel adverse drug events. She received her doctorate in biomedical informatics at Columbia University.